Poehling Capital Management’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,290
Closed -$2.31M 135
2024
Q2
$2.31M Sell
12,290
-875
-7% -$162K 0.63% 50
2024
Q1
$2.43M Sell
13,165
-65
-0.5% -$12.1K 0.65% 47
2023
Q4
$2.41M Sell
13,230
-142
-1% -$24.6K 0.76% 43
2023
Q3
$2.36M Buy
13,372
+172
+1% +$32.4K 0.82% 39
2023
Q2
$2.48M Sell
13,200
-561
-4% -$106K 0.84% 38
2023
Q1
$2.68M Sell
13,761
-165
-1% -$30.7K 0.9% 36
2022
Q4
$2.55M Sell
13,926
-858
-6% -$135K 0.96% 32
2022
Q3
$2.02M Buy
14,784
+369
+3% +$57.3K 0.85% 34
2022
Q2
$2.18M Sell
14,415
-1,295
-8% -$210K 0.82% 36
2022
Q1
$2.82M Sell
15,710
-144
-0.9% -$24.5K 0.87% 34
2021
Q4
$2.75M Sell
15,854
-289
-2% -$52.5K 0.89% 38
2021
Q3
$3M Buy
16,143
+2,586
+19% +$442K 1.01% 36
2021
Q2
$2.34M Buy
13,557
+5,617
+71% +$1.02M 0.75% 54
2021
Q1
$1.43M Buy
+7,940
New +$1.46M 0.5% 70

Other funds holding MSGS

Poehling Capital Management's MSGS Position: Q3 2024 in Review

Poehling Capital Management sold out of Madison Square Garden (MSGS) in Q3 2024, closing a stake of 12,290 shares — an estimated $2.31M sold.

Poehling Capital Management first reported a position in MSGS in Q1 2021 and held it in 14 quarters. The position peaked at $3M in Q3 2021. 326 funds tracked by Wall St. Rank hold MSGS as of Q3 2024.

  • Poehling Capital Management reported no remaining Madison Square Garden position as of Q3 2024 after selling out during the quarter.
  • Poehling Capital Management sold 12,290 Madison Square Garden shares in Q3 2024, an estimated $2.31M.
  • Poehling Capital Management first reported a position in Madison Square Garden in Q1 2021 and held it in 14 quarters.
  • Poehling Capital Management's Madison Square Garden position peaked at $3M in Q3 2021.
  • 326 funds tracked by Wall St. Rank held Madison Square Garden as of Q3 2024.

Based on Poehling Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.